Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT04880369
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with breast cancer at "Brystkirurgisk Afdeling" at Rigshospitalet and Herlev Hospitals (within the last 30 days).
* Advised (and accepted) to receive neo-adjuvant treatment
* Primary unilateral breast cancer
* Treatment is expected to be curative
* Is expected to be able to attend surgery
Exclusion Criteria:
* Allergic to soy
* Celiac disease
* Inflammatory bowel disease
* Not understanding Danish (patient material and questionnaires are in Danish)
* Prior diagnosis of breast cancer
* Use of dietary supplements containing lignans or isoflavones three months prior to diagnosis
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04880369
Study Brief:
Protocol Section:
NCT04880369